ANALYSIS OF HEMATOLOGICAL CHANGES IN TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS ACROSS PHASE 3 INDUCTION AND MAINTENANCE STUDIES

被引：0
|
作者：
Lichtenstein, Gary R.
Moore, Gregory T.
Soonasra, Arif
Nduaka, Chudy I.
Kwok, Kenneth
Wang, Lisy
Lawendy, Nervin
Chan, Gary
Su, Chinyu
Loftus, Edward V.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1752
引用
收藏
页码：S1111 / S1111
页数：1
相关论文
共 50 条
  • [41] Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments
    Feagan, Brian
    Vermeire, Severine
    Sandborn, William J.
    Reinisch, Walter
    Tarabar, Dino
    Su, Chinyu
    Niezychowski, Wojciech
    Zhang, Haiying
    Woodworth, Deborah
    Yu, Dahong
    Sands, Bruce
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S319 - S320
  • [42] Improvement in patient-reported outcomes in 2 Phase 3 studies of tofacitinib in patients with moderately to severely active ulcerative colitis
    Panes, J.
    Su, C.
    Marren, A.
    Yu, D.
    Woodworth, D.
    Zhang, H.
    Healey, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S283 - S284
  • [43] Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
    Peyrin-Biroulet, Laurent
    Hart, Ailsa
    Bossuyt, Peter
    Long, Millie
    Allez, Matthieu
    Juillerat, Pascal
    Armuzzi, Alessandro
    Loftus, Edward, V
    Ostad-Saffari, Elham
    Scalori, Astrid
    Oh, Young S.
    Tole, Swati
    Chai, Akiko
    Pulley, Jennifer
    Lacey, Stuart
    Sandborn, William J.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 128 - 140
  • [44] Efficacy and safety of oral tofacitinib as maintenance therapy in patients with moderate to severe ulcerative colitis: results from a phase 3 randomised controlled trial
    Sandborn, W. J.
    Sands, B. E.
    Danese, S.
    D'Haens, G. R.
    Vermeire, S.
    Schreiber, S.
    Feagan, B.
    Reinisch, W.
    Friedman, G.
    Woodworth, D.
    Zhang, H.
    Lawendy, N.
    Niezychowski, W.
    Su, C.
    Panes, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S19 - S20
  • [45] EFFICACY AND SAFETY OF ORAL TOFACITINIB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM A PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Vermeire, Severine
    Schreiber, Stefan
    Feagan, Brian G.
    Reinisch, Walter
    Friedman, Gary
    Woodworth, Deborah A.
    Zhang, Haiying
    Lawendy, Nervin
    Niezychowski, Wojciech
    Su, Chinyu
    Panes, Julian
    GASTROENTEROLOGY, 2017, 152 (05) : S199 - S199
  • [46] Efficacy of tofacitinib maintenance therapy for ulcerative colitis in remitting patients vs. patients with clinical response after 8 weeks of induction treatment
    Reinisch, W.
    Osterman, M. T.
    Doherty, G.
    Marren, A.
    Woodworth, D. A.
    Lawendy, N.
    Kwok, K.
    Maller, E.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S378 - S379
  • [47] Item-Level Improvements in Inflammatory Bowel Disease Questionnaire Scores in Patients With Ulcerative Colitis Treated With Tofacitinib Induction Therapy
    Dubinsky, Marla C.
    DiBonaventura, Marco
    Fan, Haiyun
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Maller, Eric
    Thorpe, Andrew J.
    Salese, Leonardo
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S413 - S413
  • [48] IMPROVEMENT IN PATIENT-REPORTED INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE OUTCOMES, AND RELATIONSHIP WITH DISEASE ACTIVITY, IN TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS: DATA FROM THE OCTAVE CLINICAL TRIALS
    Dubinsky, Marla
    Bressler, Brian
    Armuzzi, Alessandro
    Salese, Leonardo
    DiBonaventura, Marco d.
    Maller, Eric S.
    Fan, Haiyun
    Woodworth, Deborah A.
    Su, Chinyu
    GASTROENTEROLOGY, 2019, 156 (06) : S1102 - S1102
  • [49] Comparison of Mesalazine and Balsalazide in Induction and Maintenance of Remission in Patients with Ulcerative Colitis: A Meta-Analysis
    Roja Rahimi
    Shekoufeh Nikfar
    Ali Rezaie
    Mohammad Abdollahi
    Digestive Diseases and Sciences, 2009, 54 : 712 - 721
  • [50] Comparison of Mesalazine and Balsalazide in Induction and Maintenance of Remission in Patients with Ulcerative Colitis: A Meta-Analysis
    Rahimi, Roja
    Nikfar, Shekoufeh
    Rezaie, Ali
    Abdollahi, Mohammad
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (04) : 712 - 721
12345